Experimental cell therapy for Hard-to-Treat blood cancers tested in early trial
Disease control
Terminated
This early-phase study tested a new treatment called CNTY-101 for people with certain types of blood cancer (B-cell non-Hodgkin lymphoma) that had come back or stopped responding to other treatments. The main goals were to find the safest dose and check for side effects. The stud…
Phase: PHASE1 • Sponsor: Century Therapeutics, Inc. • Aim: Disease control
Last updated May 11, 2026 20:37 UTC